Cargando…
Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428747/ https://www.ncbi.nlm.nih.gov/pubmed/36061198 http://dx.doi.org/10.3389/fgene.2022.961153 |
| _version_ | 1784779190289039360 |
|---|---|
| author | Zhang, Sibin Xiao, Xu Wang, Yu Song, Tianjun Li, Chenlong Bao, Hongbo Liu, Qing Sun, Guiyin Sun, Xiaoyang Su, Tianqi Fu, Tianjiao Wang, Yujie Liang, Peng |
| author_facet | Zhang, Sibin Xiao, Xu Wang, Yu Song, Tianjun Li, Chenlong Bao, Hongbo Liu, Qing Sun, Guiyin Sun, Xiaoyang Su, Tianqi Fu, Tianjiao Wang, Yujie Liang, Peng |
| author_sort | Zhang, Sibin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94287472022-09-01 Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma Zhang, Sibin Xiao, Xu Wang, Yu Song, Tianjun Li, Chenlong Bao, Hongbo Liu, Qing Sun, Guiyin Sun, Xiaoyang Su, Tianqi Fu, Tianjiao Wang, Yujie Liang, Peng Front Genet Genetics Frontiers Media S.A. 2022-08-17 /pmc/articles/PMC9428747/ /pubmed/36061198 http://dx.doi.org/10.3389/fgene.2022.961153 Text en Copyright © 2022 Zhang, Xiao, Wang, Song, Li, Bao, Liu, Sun, Sun, Su, Fu, Wang and Liang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Genetics Zhang, Sibin Xiao, Xu Wang, Yu Song, Tianjun Li, Chenlong Bao, Hongbo Liu, Qing Sun, Guiyin Sun, Xiaoyang Su, Tianqi Fu, Tianjiao Wang, Yujie Liang, Peng Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| title | Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| title_full | Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| title_fullStr | Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| title_full_unstemmed | Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| title_short | Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| title_sort | corrigendum: developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma |
| topic | Genetics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428747/ https://www.ncbi.nlm.nih.gov/pubmed/36061198 http://dx.doi.org/10.3389/fgene.2022.961153 |
| work_keys_str_mv | AT zhangsibin corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT xiaoxu corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT wangyu corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT songtianjun corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT lichenlong corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT baohongbo corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT liuqing corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT sunguiyin corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT sunxiaoyang corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT sutianqi corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT futianjiao corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT wangyujie corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma AT liangpeng corrigendumdevelopinganimmunerelatedsignatureforpredictingsurvivalrateandtheresponsetoimmunecheckpointinhibitorsinpatientswithglioma |